Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >
5 things to know before the stock market opens Monday
Tags Palantir Technologies Inc Politics Economy
From CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
Tags LILLY DRN Merck & Co Inc Pfizer Inc
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Stock markets PepsiCo Inc/ Walt Disney Co
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Biotech and Pharmaceuticals Science Novo Nordisk A/S
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags LILLY DRN CVS Health Corp Nutrition
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Tags US: News Merck & Co Inc LILLY DRN
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Pharmaceuticals World economy Breaking News: Davos
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Health & Science Waystar Holding Corp Breaking News: Technology
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags LILLY DRN Merck & Co Inc Business News
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Health & Science Business Biotech and Pharmaceuticals
From CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
Tags Regeneron Pharmaceuticals Inc Stock markets U/S/ Markets
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Biotech and Pharmaceuticals Moderna Inc UnitedHealth Group Inc
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Tags Earnings Business News LILLY DRN
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags LILLY DRN Novo Nordisk A/S Business News
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Labor economy Cigna Corp Health & Science
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Social issues
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Pfizer Inc Accolade Inc Bristol/Myers Squibb Co
From CNBC.com News
Cramer's Lightning Round: Uber is a buy
Tags stocks Business Nucor Corp
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Business Health & Science Health care costs
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Health & Science Business Science
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Amazon/com Inc LILLY DRN Business News
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Biotech and Pharmaceuticals Breaking news Business
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health care industry Social issues Health & Science
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Social media Cybersecurity Obesity
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Novartis AG Health care industry Bristol/Myers Squibb Co
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Biotechnology Business News LILLY DRN
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Business Economy Politics
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.